Table 2. Average acceptability ratings of survey scenarios.
Scenario | Researcher Affiliation | Identity Linkage | Consent | Mean Acceptability Rating | SD |
---|---|---|---|---|---|
1 | University | N | Repeated | 78 | 29.7 |
2* | Drug Co. | N | Repeated | 76.4 | 31.4 |
3* | University | Y | Repeated | 69.4 | 35.1 |
4 | Drug Co. | Y | Repeated | 68 | 35.7 |
5* | University | N | One-time | 67.4 | 36.1 |
6 | Drug Co. | N | One-time | 61.4 | 37.3 |
7 | University | Y | One-time | 59.3 | 38.2 |
8** | University | Y | One-time | 59 | 38.7 |
9* | Drug Co. | Y | One-time | 57.7 | 38.7 |
10 | University | N | No | 38.2 | 39.9 |
11 | Drug Co. | N | No | 34.4 | 39.8 |
12 | University | Y | No | 30.4 | 37.3 |
13 | Drug Co. | Y | No | 28.6 | 36.4 |
Scenario ratings were provided on a scale anchored at 0 (completely unacceptable) to 100 (completely acceptable) in increments of 10. Order presentation was randomized between participants in five different survey versions.
Denotes that scenario was a holdout item for model validation.
Scenario #8 duplicated scenario #7 as index of response reliability.